Table of contents

Extended reports

• T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis (13 April, 2004)

  M C Kraan, J J Haringman, H Weedon, E C Barg, M D Smith, M J Ahern, T J M Smeets, F C Breedveld, P P Tak
• Tumour necrosis factor α independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules (13 April, 2004)

  D Baeten, F De Keyser, E M Veys, Y Theate, F A Houssiau, P Durez
• Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population (13 April, 2004)

  T Sokka, A Häkkinen, E Krishnan, P Hannonen
• Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy (13 April, 2004)

  M Rihl, D Baeten, N Seta, J Gu, F De Keyser, E M Veys, J G Kuipers, H Zeidler, D T Y Yu
• Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed (13 April, 2004)

  L B A van de Putte, C Atkins, M Malaise, J Sany, A S Russell, P L C M van Riel, L Settas, J W Bijlsma, S Todesco, M Dougados, P Nash, P Emery, N Walter, M Kaul, S Fischkoff, H Kupper
• Global core recommendations for a musculoskeletal undergraduate curriculum (13 April, 2004)

  A D Woolf, N E Walsh, K Åkesson
• EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis (13 April, 2004)

  C-S Yee, C Gordon, C Dostal, P Petera, J Dadoniene, B Griffiths, B Rozman, D A Isenberg, G Sturfelt, O Nived, J H Turney, A Venalis, D Adu, J S Smolen, P Emery
• Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists (13 April, 2004)

  R Landewé, B Rump, D van der Heijde, S van der Linden
• How to diagnose axial spondyloarthritis early (13 April, 2004)

  M Rudwaleit, D van der Heijde, M A Khan, J Braun, J Sieper
• Insulin-like growth factor I gene promoter polymorphism, collagen type II α1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study (13 April, 2004)

  G Zhai, F Rivadeneira, J J Houwing-Duistermaat, I Meulenbelt, C Bijkerk, A Hofman, J B J van Meurs, A G Uitterlinden, H A P Pols, P E Slagboom, C M van Duijn
• Use of complementary medicines for osteoarthritis—a prospective study (13 April, 2004)

  J Zochling, L March, H Lapsley, M Cross, K Tribe, P Brooks
• MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years (13 April, 2004)

  N Benton, N Stewart, J Crabbe, E Robinson, S Yeoman, F M McQueen
• A multidisciplinary job retention vocational rehabilitation programme for patients with chronic rheumatic diseases: patients’ and occupational physicians’ satisfaction (13 April, 2004)

  P D M de Buck, J Breedveld, F J van der Giesen, T P M Vliet Vlieland
• Increased transendothelial migration of scleroderma lymphocytes (13 April, 2004)

  G H Stummvoll, M Aringer, J Grisar, C W Steiner, J S Smolen, R Knobler, W B Graninger
• Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjögren’s syndrome: a case–control study (13 April, 2004)

  R Tunc, M S Gonen, O Acbay, V Hamuryudan, H Yazici
• Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression (13 April, 2004)

  S Giannouli, D Tzoanopoulos, K Ritis, G Kartalis, H M Moutsopoulos, M Voulgarelis
• Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis (13 April, 2004)

  K Yanaba, K Takehara, S Sato